Atlas Trials

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

Clinical trial NCT00002014 · COMPLETED

Trial details

NCT number
NCT00002014
Sponsor
Glaxo Wellcome
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.